Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
Guidelines
MIRAGE
Alliance of Genome Resources

Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.

Source Last Updated
Alliance of Genome Resources January 28, 2025
Displaying entries 426 - 450 of 14279 in total
Disease ID Disease Name Alliance of Genome Resources ID Species Gene ID ▼ Gene Symbol FlyGlycoDB Evidence References
DOID:535 sleep disorder MGI:2441738 Mus musculus (house mouse) 319239 Npsr1 author statement supported by traceable reference
  • PMID:31619542
DOID:1574 alcohol use disorder FB:FBgn0053182 Drosophila melanogaster (fruit fly) 318918 Kdm4B combinatorial experimental and author inference evidence used in manual assertion
  • PMID:28940624
DOID:2349 arteriosclerosis RGD:1309438 Rattus norvegicus (Norway rat) 313121 Map3k7 mutant phenotype evidence used in manual assertion
  • PMID:35078016
DOID:0070355 overactive bladder syndrome RGD:1303284 Rattus norvegicus (Norway rat) 312896 Trpa1 mutant phenotype evidence used in manual assertion
  • PMID:21367919
DOID:9743 diabetic neuropathy RGD:1303284 Rattus norvegicus (Norway rat) 312896 Trpa1 mutant phenotype evidence used in manual assertion
  • PMID:22133672
DOID:2841 asthma RGD:1303284 Rattus norvegicus (Norway rat) 312896 Trpa1 mutant phenotype evidence used in manual assertion
  • PMID:31969645
DOID:0070355 overactive bladder syndrome RGD:1598328 Rattus norvegicus (Norway rat) 310738 Ngf direct assay evidence used in manual assertion
  • PMID:21605172
  • PMID:22473863
DOID:90 degenerative disc disease RGD:1598328 Rattus norvegicus (Norway rat) 310738 Ngf mutant phenotype evidence used in manual assertion
  • PMID:20973063
DOID:0081292 traumatic brain injury RGD:1598328 Rattus norvegicus (Norway rat) 310738 Ngf mutant phenotype evidence used in manual assertion
  • PMID:26285082
DOID:3525 middle cerebral artery infarction RGD:1598328 Rattus norvegicus (Norway rat) 310738 Ngf mutant phenotype evidence used in manual assertion
  • PMID:29409115
DOID:13948 bladder neck obstruction RGD:1598328 Rattus norvegicus (Norway rat) 310738 Ngf direct assay evidence used in manual assertion
  • PMID:22795377
DOID:8947 diabetic retinopathy RGD:1598328 Rattus norvegicus (Norway rat) 310738 Ngf mutant phenotype evidence used in manual assertion
  • PMID:24030532
DOID:0080809 chronic asthma RGD:1598328 Rattus norvegicus (Norway rat) 310738 Ngf mutant phenotype evidence used in manual assertion
  • PMID:30681402
DOID:8398 osteoarthritis RGD:1598328 Rattus norvegicus (Norway rat) 310738 Ngf mutant phenotype evidence used in manual assertion
  • PMID:25677108
  • PMID:33806315
DOID:1679 cystitis RGD:1598328 Rattus norvegicus (Norway rat) 310738 Ngf mutant phenotype evidence used in manual assertion
  • PMID:19996110
DOID:12143 neurogenic bladder RGD:1598328 Rattus norvegicus (Norway rat) 310738 Ngf direct assay evidence used in manual assertion
  • PMID:22220508
DOID:9352 type 2 diabetes mellitus RGD:1308903 Rattus norvegicus (Norway rat) 310615 Crtc2 mutant phenotype evidence used in manual assertion
  • PMID:19706791
  • PMID:23595987
DOID:9279 hyperhomocysteinemia RGD:1359175 Rattus norvegicus (Norway rat) 306761 F12 direct assay evidence used in manual assertion
  • PMID:16046705
DOID:8398 osteoarthritis RGD:735196 Rattus norvegicus (Norway rat) 304135 Adamts5 mutant phenotype evidence used in manual assertion
  • PMID:23546441
DOID:1686 glaucoma RGD:728890 Rattus norvegicus (Norway rat) 302668 Ace2 direct assay evidence used in manual assertion
  • PMID:23702784
DOID:5844 myocardial infarction RGD:728890 Rattus norvegicus (Norway rat) 302668 Ace2 direct assay evidence used in manual assertion
  • PMID:23959549
DOID:0060903 thrombosis RGD:728890 Rattus norvegicus (Norway rat) 302668 Ace2 direct assay evidence used in manual assertion
  • PMID:20111697
DOID:3345 xanthomatosis RGD:2998 Rattus norvegicus (Norway rat) 300438 Ldlr mutant phenotype evidence used in manual assertion
  • PMID:22293196
DOID:10230 aortic atherosclerosis RGD:2998 Rattus norvegicus (Norway rat) 300438 Ldlr mutant phenotype evidence used in manual assertion
  • PMID:29459263
DOID:9452 steatotic liver disease RGD:2998 Rattus norvegicus (Norway rat) 300438 Ldlr mutant phenotype evidence used in manual assertion
  • PMID:29459263
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback

Click here to visit the beta site.

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.4.0

Last updated: December 8, 2025